Subscribe in a reader

Cambridge MedChem Consulting

Open science ASAP antiviral discovery center

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern. One of the centres is the AI-Driven Structure-Enabled Antiviral Platform (ASAP)

ASAP uses artificial intelligence and computational chemistry to accelerate structure-based open science antiviral drug discovery and deliver oral antivirals for pandemics with the goal of global, equitable, and affordable access.

ASAP Overview


They are currently recruiting for multiple positions, so if you would like to be involved in this exciting programme head over to